Status:
COMPLETED
Activated Protein C and Microcirculation
Lead Sponsor:
Università Politecnica delle Marche
Collaborating Sponsors:
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Conditions:
Severe Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Objective: to test the hypothesis that recombinant activated protein C (aPC) therapy improves the microcirculation of severe septic patients. Design: Prospective, open study. Setting: University 12-b...
Eligibility Criteria
Inclusion
- Septic patients with at least two sepsis-induced organ failures occurring within 48 hours of the onset of sepsis
Exclusion
- hematologic or advanced malignancies
- liver cirrhosis
- severely impaired consciousness (Glasgow Coma Scale score \<7 of 15)
- therapeutic limitations (do-not-resuscitate orders)
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01806428
Start Date
July 1 2009
End Date
August 1 2011
Last Update
October 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University ICU, AOU Ospedali Riuniti Ancona
Torrette Di Ancona, Ancona, Italy, 60126